The Global Hyaluronic Acid Market has been projected to grow at the CAGR of 9% market during 2017-2025. In 2016, the market has generated the revenue of $ 8.3 billion and is expected to reach $ 13.4 billion in terms of revenue by 2025.
Increasing demand relating to anti-aging processes has resulted in increase in demand for global hyaluronic acid market. Hyaluronic acid, also known as hyaluronan, are organic compounds belonging to the branch of carbohydrates and further to its polysaccharides segment. Hyaluronic acid is prepared in laboratory by various processes including extraction from rooster combs, in-vitro and bacterial production. It is a non-sulfated glycosaminoglycan which is present in the connective, neural and epithelial tissues of living organisms. Owing to its hydrophilic nature, hyaluronic acid is used as lubricant and shock absorber in various joint disorders, including osteoarthritis. However, it can be injected into the affected joint or taken by mouth as per directed by healthcare professional.
Market Segment Insights
The product type segments covered in the study include single, three and five injections. Five injections is the largest application segment for hyaluronic acid. It accounted for 40% share of the market in 2016 in terms of revenue. The market is mainly driven by high usage associated with it. Single injection segment is projected to be the highest growth segment of the market, which is primarily driven by the benefits associated with it. The application segments include vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis. Dermal fillers is the largest application segment for hyaluronic acid. It accounted for 37% share of the market in 2016 in terms of revenue. Vesicoureteral reflux segment is projected to be the highest growth segment of the market.
North America is the largest market for hyaluronic acid and accounted for 38% share of the market in 2014. The market is primarily boosted by growing aged population and their treatment needs. North America is projected to maintain its dominance during the forecast period. Asia Pacific is projected to be the fastest growing market for hyaluronic acid products. Growing awareness among the population and enhancement in health care infrastructure is the major factor attributing towards the market growth.
Market Competition Assessment:
The major players currently operating in the global hyaluronic acid market include Anika Therapeutics, Inc., Allergan plc, Sanofi S.A., Ferring B.V., Seikagaku Corporation, AstraZeneca, Salix Pharmaceutical, Inc., Fidia Farmaceutici, and Zimmer Biomet.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Hyaluronic Acid Market Portraiture
2.2 Global Hyaluronic Acid Market, by Product, 2016 ($ Million)
2.3 Global Hyaluronic Acid Market, by Application, 2016 ($ Million)
2.4 Global Hyaluronic Acid Market, by Geography, 2016 (Value %)
Chapter 3 Global Hyaluronic Acid Market Analysis
3.1 Global Hyaluronic Acid Market Overview
3.2 Major Market Trends and Key Takeaways
3.3 Market Dynamics
3.3.1 Market Drivers
18.104.22.168 Increasing use of hyaluronic acid in treatments of dry eyes, mouth sores, and aging skin is expected to drive the market growth
22.214.171.124 Substitution from cost-effective treatments along with several regulations concerns to restrain the market growth
3.4 Attractive Investment Proposition
3.5 Competitive Analysis: Global Hyaluronic Acid Market, 2015 (Value %)
Chapter 4 Global Hyaluronic Acid Market, by Product, 2015-2025 ($ Million)
4.2 Single Injection
4.3 Three Injection
4.4 Five Injections
Chapter 5 Global Hyaluronic Acid Market, by Application, 2015-2025 ($ Million)
5.2 Dermal Fillers
5.5 Vesicoureteral Reflux (VUR)
Chapter 6 Global Hyaluronic Acid Market, by Geography, 2015-2025 ($ Million)
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, Singapore, South Korea and Rest of APAC)
6.5 Latin America (Mexico, Brazil and Rest of LATAM)
6.6 Middle East and Africa (GCC, and Rest of Middle East and Africa)
Chapter 6 Company Profiles
6.1 Anika Therapeutics, Inc.
6.2 Allergan plc
6.3 Sanofi S.A.
6.4 Ferring B.V.
6.5 Seikagaku Corporation
6.7 Salix Pharmaceutical, Inc.
6.8 Fidia Farmaceutici
6.9 Zimmer Biomet